The following were presented by ValueMedics at the 9th Annual ISPOR Meeting May 16-19, 2004

CAPTURING THE VALUE OF PHARMACEUTICALS: THE ROLE OF OUTCOMES RESEARCH IN PRICING DECISIONS
Tierce JC¹, LaPensee KT², Wierz DJ³, Sugano DS^4
1ValueMedics Research, LLC, Alexandria, VA, USA;²Skylands Healthcare Consulting, LLC., formerly of Cambridge Pharma Consultancy^*, Hampton, NJ, USA; ³Independent Consultant, formerly of Wyeth, Inc, Exton, PA, USA; ⁴Schering-Plough Corporation, Kenilworth, NJ, USA

COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN COMPARED TO ATORVASTATIN, FLUVASTATIN, LOVASTATIN, PRAVASTATIN, AND SIMVASTATIN
Benner JS¹, Smith TW¹, Klingman D¹, Tierce JC¹, Mullins CD², Pethick N³, O'Donnell J^3
1ValueMedics Research, LLC, Arlington, VA, USA; ²University of Maryland, Baltimore, MD, USA; ³Astrazeneca LP, Wilmington, DE, USA

PREDICTORS OF ADHERENCE WITH CONCOMITANT ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY
Chapman RH¹, Benner JS ¹, Petrilla AA ¹, Tierce JC ¹, Battleman DS², Schwartz JS^3
1ValueMedics Research, LLC, Arlington, VA, USA; ²Pfizer Inc, New York, NY, USA; ³University of Pennsylvania, Philadelphia,PA, USA

CLINICAL AND ECONOMIC OUTCOMES OF NON-ADHERENCE TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV
Munakata J¹, Benner JS¹, Becker SL², Dezii CM³, Hazard EH¹, Tierce JC^{1 1}ValueMedics Research, LLC, Arlington, VA, USA; ²Pacific Horizon Medical Group, Inc, San Francisco, CA, USA; ³Bristol-Myers Squibb, Plainsboro, NJ, USA